AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33932394 — intervention group
Group type: COMPARATOR
Intervention: 1 mL of 100 μg.mL‐1 dexmedetomidine (group D) with 30 mL of 0.5% bupivacaine
Number of subjects: 40
Study 33525934 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Infrared Laser Stimulation (TILS)
Number of subjects: 5
Study 33525934 — intervention group
Group type: COMPARATOR
Intervention: Sham control (not explicitly detailed in the abstract)
Number of subjects: 5
Study 32369401 — intervention group
Group type: EXPERIMENTAL
Intervention: Text Messaging (TM)
Number of subjects: 702
Study 32369401 — intervention group
Group type: COMPARATOR
Intervention: No Text Messaging (No-TM)
Number of subjects: 702
Study 35767915 — intervention group
Group type: EXPERIMENTAL
Intervention: AST-120
Number of subjects: 149
Study 34160286 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk
Number of subjects: 50
Study 34160286 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea
Number of subjects: 50
Study 34160286 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange juice
Number of subjects: 50
Study 34160286 — intervention group
Group type: EXPERIMENTAL
Intervention: Cola
Number of subjects: 50
Study 34160286 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 50
Study 33047540 — intervention group
Group type: EXPERIMENTAL
Intervention: Y-STR genetic markers (27 markers)
Number of subjects: 1702
Study 33047540 — intervention group
Group type: EXPERIMENTAL
Intervention: DYS385
Number of subjects: 1702
Study 33047540 — intervention group
Group type: EXPERIMENTAL
Intervention: DYS438
Number of subjects: 1702
Study 33047540 — intervention group
Group type: EXPERIMENTAL
Intervention: Y-Predictor software
Number of subjects: 1702
Study 33771763 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb12, 10^9 colony-forming units, orally, once daily for 6 months
Number of subjects: 96
Study 33771763 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 33771763 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb12
Number of subjects: 96
Study 36335645 — intervention group
Group type: EXPERIMENTAL
Intervention: Mavacamten
Number of subjects: 98
Study 36335645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 33562861 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped-Mastery Contact Model (FMCM)
Number of subjects: 85
Study 33562861 — intervention group
Group type: COMPARATOR
Intervention: Flipped-Mastery Untact Model (FMUM)
Number of subjects: 85
Study 32519219 — intervention group
Group type: EXPERIMENTAL
Intervention: VOCAL-Penn model for ACLF development at 3 months
Number of subjects: 75922
Study 32519219 — intervention group
Group type: EXPERIMENTAL
Intervention: VOCAL-Penn model for ACLF development at 6 months
Number of subjects: 75922
Study 32519219 — intervention group
Group type: EXPERIMENTAL
Intervention: VOCAL-Penn model for ACLF development at 12 months
Number of subjects: 75922
Study 32519219 — intervention group
Group type: EXPERIMENTAL
Intervention: VOCAL-Penn model for ACLF mortality at 28 days
Number of subjects: 75922
Study 32519219 — intervention group
Group type: EXPERIMENTAL
Intervention: VOCAL-Penn model for ACLF mortality at 90 days
Number of subjects: 75922
Study 32519219 — intervention group
Group type: COMPARATOR
Intervention: Comparison with MELD, MELD-sodium, and APASL ACLF scores
Number of subjects: 75922
Study 33340514 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 90
Study 33340514 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load Resistance Training with Blood Flow Restriction (RT+BFR)
Number of subjects: 90
Study 33340514 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CTL)
Number of subjects: 90
Study 33186351 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline MRI findings
Number of subjects: 48
Study 33186351 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up MRI findings after two months
Number of subjects: 48
Study 33186351 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of multiple brain lesions
Number of subjects: 48
Study 33186351 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline and follow-up MRI findings and paradoxical responses
Number of subjects: 48
Study 36239287 — intervention group
Group type: EXPERIMENTAL
Intervention: Low carbohydrate, high fat (LCHF) diet
Number of subjects: 14
Study 36239287 — intervention group
Group type: COMPARATOR
Intervention: High carbohydrate (HC) diet
Number of subjects: 14
Study 33398914 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (n = 667)
Number of subjects: 926
Study 33398914 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (n = 259)
Number of subjects: 926
Study 32449396 — intervention group
Group type: EXPERIMENTAL
Intervention: New brochure
Number of subjects: 240
Study 32449396 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health worker (CHW) delivered new brochure's content
Number of subjects: 240
Study 32449396 — intervention group
Group type: COMPARATOR
Intervention: Standard educational brochure (Control)
Number of subjects: 240
Study 37645033 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole as adjunctive therapy with valproate sodium
Number of subjects: 64
Study 37645033 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone as adjunctive therapy with valproate sodium
Number of subjects: 64
Study 33948768 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS group (n = 41)
Number of subjects: 54
Study 33948768 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 54
Study 35403396 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye acupuncture + Tengliao + rehabilitation
Number of subjects: 356
Study 35403396 — intervention group
Group type: COMPARATOR
Intervention: Tengliao + rehabilitation
Number of subjects: 356
Study 35403396 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation
Number of subjects: 356
Study 34126858 — intervention group
Group type: EXPERIMENTAL
Intervention: eCHECKUP TO GO (eCTG) intervention
Number of subjects: 227
Study 34126858 — intervention group
Group type: COMPARATOR
Intervention: Healthy Stress Management (HSM) control
Number of subjects: 227
Study 34373987 — intervention group
Group type: EXPERIMENTAL
Intervention: Household water insecurity score (5-unit increase)
Number of subjects: 716
Study 34373987 — intervention group
Group type: EXPERIMENTAL
Intervention: Household water insecurity
Number of subjects: 716
Study 34927590 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable activity tracker + 6 weekly behavioral support emails
Number of subjects: 49
Study 34927590 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable activity tracker
Number of subjects: 49
Study 34927590 — intervention group
Group type: COMPARATOR
Intervention: Control group (copy of Canadian PA guidelines only)
Number of subjects: 49
Study 34927590 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 49
Study 32875989 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 172
Study 32875989 — intervention group
Group type: COMPARATOR
Intervention: Liraglutide
Number of subjects: 172
Study 32875989 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin and Liraglutide
Number of subjects: 172
Study 33877002 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger disc area
Number of subjects: 0
Study 33877002 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased neuroretinal rim volume
Number of subjects: 0
Study 33877002 — intervention group
Group type: EXPERIMENTAL
Intervention: Thicker RNFL
Number of subjects: 0
Study 33847150 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong intervention for 6 weeks
Number of subjects: 156
Study 33847150 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong intervention
Number of subjects: 156
Study 33847150 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group receiving usual care
Number of subjects: 156
Study 32761176 — intervention group
Group type: COMPARATOR
Intervention: Routine health facility data (API)
Number of subjects: 5580
Study 32761176 — intervention group
Group type: EXPERIMENTAL
Intervention: Serological measures (gold-standard)
Number of subjects: 5580
Study 36299880 — intervention group
Group type: EXPERIMENTAL
Intervention: Kunbixiao granule (KBXG)
Number of subjects: 90
Study 36299880 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 32423331 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitonin gene‐related peptide
Number of subjects: 26
Study 32423331 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 26
Study 34962008 — intervention group
Group type: EXPERIMENTAL
Intervention: Early skin-to-skin contact
Number of subjects: 241
Study 34962008 — intervention group
Group type: COMPARATOR
Intervention: Traditional neonatal care
Number of subjects: 241
Study 33675044 — intervention group
Group type: EXPERIMENTAL
Intervention: Papaverine
Number of subjects: 498
Study 33675044 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 498
Study 32215467 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group received printed guidelines and a demonstration and training session with a physical therapist in a simulated environment.
Number of subjects: 68
Study 32215467 — intervention group
Group type: COMPARATOR
Intervention: Control Group received only printed guidelines regarding the postoperative period.
Number of subjects: 68
Study 35157551 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-affirmation (n=43)
Number of subjects: 88
Study 35157551 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=45)
Number of subjects: 88
Study 33256485 — intervention group
Group type: EXPERIMENTAL
Intervention: Ready-made spectacles available programme
Number of subjects: 1000
Study 33256485 — intervention group
Group type: COMPARATOR
Intervention: Custom-made spectacles only programme
Number of subjects: 1000
Study 616625220 — intervention group
Group type: EXPERIMENTAL
Intervention: EOAP regimen combined with Chansu injection (20 ml/d, intravenous drip, on d 1-14)
Number of subjects: 65
Study 616625220 — intervention group
Group type: COMPARATOR
Intervention: EOAP regimen alone
Number of subjects: 65
Study 34479999 — intervention group
Group type: EXPERIMENTAL
Intervention: Interacting groups solving complex tasks
Number of subjects: 1200
Study 34479999 — intervention group
Group type: EXPERIMENTAL
Intervention: Interacting groups solving simpler tasks
Number of subjects: 1200
Study 34479999 — intervention group
Group type: EXPERIMENTAL
Intervention: Interacting groups
Number of subjects: 1200
Study 34479999 — intervention group
Group type: COMPARATOR
Intervention: Independent individuals
Number of subjects: 1200
Study 32628359 — intervention group
Group type: EXPERIMENTAL
Intervention: SCO-101
Number of subjects: 92
Study 32628359 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 35926260 — intervention group
Group type: EXPERIMENTAL
Intervention: Board game play (experimental group, n=35)
Number of subjects: 69
Study 35926260 — intervention group
Group type: COMPARATOR
Intervention: Didactic lecture (comparison group, n=34)
Number of subjects: 69
Study 32334635 — intervention group
Group type: COMPARATOR
Intervention: Clinical model
Number of subjects: 390
Study 32334635 — intervention group
Group type: COMPARATOR
Intervention: Patient-demographic model
Number of subjects: 390
Study 32334635 — intervention group
Group type: COMPARATOR
Intervention: Radiomic-derived model
Number of subjects: 390
Study 34991359 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative binomial regression
Number of subjects: 0
Study 32022827 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk reduction through family therapy (RRFT)
Number of subjects: 124
Study 32022827 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 124
Study 34448546 — intervention group
Group type: EXPERIMENTAL
Intervention: Partnership Care Model (PCM)
Number of subjects: 67
Study 34448546 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 67
Study 32986655 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates exercise group (n=20)
Number of subjects: 40
Study 32986655 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=20)
Number of subjects: 40
Study 32808345 — intervention group
Group type: EXPERIMENTAL
Intervention: Freestyle swim training (8 weeks, 3 times a week, 30 min per session, increased to 40 min after 4 weeks)
Number of subjects: 26
Study 32808345 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 26
Study 36253078 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized estimating equations (GEE) analysis for complete and incomplete stepped wedge designs
Number of subjects: 6
Study 36253078 — intervention group
Group type: EXPERIMENTAL
Intervention: Analytical power method
Number of subjects: 6
Study 36253078 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimation using the correctly specified model-based variance estimator
Number of subjects: 6
Study 36253078 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast GEE power method
Number of subjects: 6
Study 33694358 — intervention group
Group type: EXPERIMENTAL
Intervention: taVNS (15 min)
Number of subjects: 27
Study 33694358 — intervention group
Group type: EXPERIMENTAL
Intervention: OA-D (5 min followed by 10 min rest)
Number of subjects: 27
Study 33694358 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention for 15 min)
Number of subjects: 27
Study 33451978 — intervention group
Group type: COMPARATOR
Intervention: Sipuleucel-T
Number of subjects: 32
Study 33451978 — intervention group
Group type: EXPERIMENTAL
Intervention: Radium-223 + Sipuleucel-T
Number of subjects: 32
Study 32454417 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (100 mg/m2/day on days 1, 22 and 43 of radiotherapy)
Number of subjects: 116
Study 32454417 — intervention group
Group type: COMPARATOR
Intervention: Cetuximab (400 mg/m2 loading dose, 250 mg/m2/week during radiotherapy)
Number of subjects: 116
Study 35186114 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 µg/kg before skin incision for 10 min, followed by intravenous infusion at 0.4 µg·kg‐1·h‐1 until 30 min before surgery.
Number of subjects: 70
Study 35186114 — intervention group
Group type: COMPARATOR
Intervention: Normal saline before skin resection (control group).
Number of subjects: 70
Study 33788154 — intervention group
Group type: EXPERIMENTAL
Intervention: SUVN-D4010 (25 mg single dose)
Number of subjects: 0
Study 33788154 — intervention group
Group type: EXPERIMENTAL
Intervention: SUVN-D4010 (up to 45 mg single dose and up to 40 mg once daily for 14 days)
Number of subjects: 0
Study 33788154 — intervention group
Group type: COMPARATOR
Intervention: SUVN-D4010 (fed vs fasted state)
Number of subjects: 0
Study 35030564 — intervention group
Group type: EXPERIMENTAL
Intervention: High-value elements (HVE) intervention
Number of subjects: 16099
Study 35030564 — intervention group
Group type: COMPARATOR
Intervention: Quality improvement goals (control)
Number of subjects: 16099
Study 34672064 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.33% hydrocortisone sodium phosphate solution
Number of subjects: 0
Study 34672064 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.001% hydrocortisone sodium phosphate solution
Number of subjects: 0
Study 34672064 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 0
Study 35243305 — intervention group
Group type: EXPERIMENTAL
Intervention: Direction and angle marking on forearm skin (intervention group)
Number of subjects: 83
Study 35243305 — intervention group
Group type: COMPARATOR
Intervention: No structured cannulation information system (control group)
Number of subjects: 83
Study 35724496 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation (CR) plus treatment-as-usual (TAU)
Number of subjects: 80
Study 35724496 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 80
Study 32162448 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich drink
Number of subjects: 16
Study 32162448 — intervention group
Group type: COMPARATOR
Intervention: 5% glucose solution
Number of subjects: 16
Study 35907781 — intervention group
Group type: EXPERIMENTAL
Intervention: Yokukansan (TJ-54)
Number of subjects: 149
Study 35907781 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 34850657 — intervention group
Group type: EXPERIMENTAL
Intervention: Oseltamivir treatment
Number of subjects: 277
Study 35477377 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose intrathecal morphine (100 µg) with 12.5 mg of 0.5% hyperbaric bupivacaine
Number of subjects: 80
Study 35477377 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil PCIA (100 µg) with 12.5 mg of 0.5% hyperbaric bupivacaine
Number of subjects: 80
Study 35477377 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose intrathecal morphine (100 µg)
Number of subjects: 80
Study 35477377 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil PCIA (100 µg)
Number of subjects: 80
Study 35477377 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 32001481 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab plus paclitaxel protein-bound
Number of subjects: 0
Study 32001481 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus paclitaxel protein-bound
Number of subjects: 0
Study 35314926 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 32
Study 35314926 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (control)
Number of subjects: 32
Study 32134961 — intervention group
Group type: EXPERIMENTAL
Intervention: Paternal involvement
Number of subjects: 104
Study 35405011 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly somatrogon (0.66 mg/kg/week)
Number of subjects: 228
Study 35405011 — intervention group
Group type: COMPARATOR
Intervention: Once-daily somatropin (0.24 mg/kg/week)
Number of subjects: 228
Study 35405011 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 228
Study 35405011 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly somatrogon
Number of subjects: 228
Study 34476342 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium (1000 mg) plus Vitamin D (400 IU) supplementation
Number of subjects: 36282
Study 34476342 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium (1000 mg) plus Vitamin D (400 IU) supplementation with personal supplements
Number of subjects: 36282
Study 34476342 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36282
Study 32065769 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear Exercise Training (LET)
Number of subjects: 174
Study 32065769 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonlinear Exercise Training (NLET)
Number of subjects: 174
Study 32065769 — intervention group
Group type: COMPARATOR
Intervention: Attention Control (Stretching)
Number of subjects: 174
Study 35316819 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve Growth Factor (NGF) injection
Number of subjects: 40
Study 32044905 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (FO, n = 38, 2 g day‐1 EPA + DHA)
Number of subjects: 77
Study 32044905 — intervention group
Group type: COMPARATOR
Intervention: Control corn oil (CO, n = 39)
Number of subjects: 77
Study 32777896 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous oxycodone (0.1 mg kg–1) administered 20 min before intubation
Number of subjects: 6
Study 33401232 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilization with movement (MWM)
Number of subjects: 32
Study 35974309 — intervention group
Group type: COMPARATOR
Intervention: alfentanil and propofol (AP) group
Number of subjects: 120
Study 35974309 — intervention group
Group type: EXPERIMENTAL
Intervention: alfentanil and remimazolam 0.1 mg/kg (AR1 group)
Number of subjects: 120
Study 35974309 — intervention group
Group type: EXPERIMENTAL
Intervention: alfentanil and remimazolam 0.15 mg/kg (AR2 group)
Number of subjects: 120
Study 35974309 — intervention group
Group type: EXPERIMENTAL
Intervention: alfentanil and remimazolam 0.2 mg/kg (AR3 group)
Number of subjects: 120
Study 34106250 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS under placebo medication
Number of subjects: 12
Study 34106250 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS under placebo medication
Number of subjects: 12
Study 34106250 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS under citalopram (20 mg/40 mg)
Number of subjects: 12
Study 34106250 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS under citalopram (40 mg)
Number of subjects: 12
Study 34106250 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS under citalopram (20 mg)
Number of subjects: 12
Study 34106250 — intervention group
Group type: COMPARATOR
Intervention: Placebo medication
Number of subjects: 12
Study 34982507 — intervention group
Group type: EXPERIMENTAL
Intervention: DA‐5520 with laser resurfacing (test 1)
Number of subjects: 36
Study 34982507 — intervention group
Group type: EXPERIMENTAL
Intervention: DA‐5520 with comedone extraction (test 2)
Number of subjects: 36
Study 34982507 — intervention group
Group type: COMPARATOR
Intervention: Moisturizers alone (control 1)
Number of subjects: 36
Study 34982507 — intervention group
Group type: COMPARATOR
Intervention: Moisturizers alone (control 2)
Number of subjects: 36
Study 33772124 — intervention group
Group type: EXPERIMENTAL
Intervention: Active intervention group (AG) with multiple interventions including training courses for nurses on dental health, oral health-related information cards (OHICs), and atraumatic restorative treatment (ART)-trained dentists
Number of subjects: 368
Study 33772124 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive intervention group (PG) implementing OHICs and ART-trained dentists
Number of subjects: 368
Study 33772124 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) receiving a 45-minute lecture on oral health
Number of subjects: 368
Study 35902950 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram prediction model based on risk factors (gender, primary diagnosis, postoperative residual pain, poor postoperative range of motion, wound healing, rate of change in HKA)
Number of subjects: 208
Study 35902950 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram prediction model
Number of subjects: 208
Study 34990170 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive Leadership Training (SLT)
Number of subjects: 496